Author: Alberca, Gabriela Gama Freire; Solis-Castro, Rosa Liliana; Solis-Castro, Maria Edith; Alberca, Ricardo Wesley
Title: Coronavirus disease–2019 and the intestinal tract: An overview Cord-id: ezb7g9fa Document date: 2021_4_7
ID: ezb7g9fa
Snippet: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease–2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestin
Document: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease–2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestinal SARS-CoV-2 infection and other viral gastrointestinal infections, some patients may develop alterations in the gastrointestinal microbiota. In addition, some COVID-19 patients may receive antibiotics, which may also disturb gastrointestinal homeostasis. In summary, the gastrointestinal system, gut microbiome, and gut-lung axis may represent an important role in the development, severity, and treatment of COVID-19. Therefore, in this review, we explore the current pieces of evidence of COVID-19 gastrointestinal manifestations, possible implications, and interventions.
Search related documents:
Co phrase search for related documents- abdominal pain and adjuvant treatment: 1
- abdominal pain and local inflammation: 1, 2
- aberrant release and acute respiratory syndrome: 1, 2
- acid produce and acute respiratory syndrome: 1
- acid sensitive and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
- actinobacteria firmicutes and acute respiratory syndrome: 1
- activity growth and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activity growth and adaptive immune system: 1
- acute respiratory syndrome and adaptive immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adjuvant treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute respiratory syndrome and local immune response: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and local intestinal: 1, 2, 3
- acute respiratory syndrome and long term consequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- adaptive immune system and local immune response: 1, 2
- adaptive immune system and local inflammation: 1, 2
Co phrase search for related documents, hyperlinks ordered by date